A detailed history of Ci Investments Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Ci Investments Inc. holds 502,546 shares of PFE stock, worth $13.4 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
502,546
Previous 476,719 5.42%
Holding current value
$13.4 Million
Previous $13.3 Million 9.03%
% of portfolio
0.06%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$27.7 - $31.39 $715,407 - $810,709
25,827 Added 5.42%
502,546 $14.5 Million
Q2 2024

Aug 12, 2024

BUY
$25.26 - $29.6 $4.22 Million - $4.95 Million
167,221 Added 54.03%
476,719 $13.3 Million
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $1.14 Million - $1.3 Million
43,878 Added 16.52%
309,498 $8.59 Million
Q4 2023

Feb 12, 2024

SELL
$26.13 - $33.94 $4.74 Million - $6.16 Million
-181,456 Reduced 40.59%
265,620 $7.65 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $216,703 - $253,305
-6,753 Reduced 1.49%
447,076 $14.8 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $8.87 Million - $10.3 Million
-245,658 Reduced 35.12%
453,829 $16.6 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $5.21 Million - $6.78 Million
-132,288 Reduced 15.9%
699,487 $28.5 Million
Q4 2022

Feb 10, 2023

BUY
$41.75 - $54.5 $47,428 - $61,912
1,136 Added 0.14%
831,775 $42.6 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $371,872 - $453,963
8,498 Added 1.03%
830,639 $36.3 Million
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $17.6 Million - $20.9 Million
-378,246 Reduced 31.51%
822,141 $43.1 Million
Q1 2022

May 12, 2022

BUY
$45.75 - $56.69 $6.8 Million - $8.43 Million
148,643 Added 14.13%
1,200,387 $62.1 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $10.1 Million - $14.9 Million
243,856 Added 30.18%
1,051,744 $62.1 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $3.5 Million - $4.49 Million
-89,112 Reduced 9.93%
807,888 $34.7 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $531,432 - $602,023
14,799 Added 1.68%
897,000 $35.1 Million
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $3.33 Million - $3.76 Million
-99,541 Reduced 10.14%
882,201 $32 Million
Q4 2020

Feb 09, 2021

BUY
$33.47 - $42.56 $6.53 Million - $8.3 Million
194,976 Added 24.78%
981,742 $36.1 Million
Q3 2020

Nov 09, 2020

SELL
$31.75 - $37.25 $930,179 - $1.09 Million
-29,297 Reduced 3.59%
786,766 $28.9 Million
Q2 2020

Aug 07, 2020

BUY
$30.12 - $36.54 $4.3 Million - $5.22 Million
142,918 Added 21.23%
816,063 $26.7 Million
Q1 2020

Aug 07, 2020

SELL
$27.03 - $38.62 $7.29 Million - $10.4 Million
-269,739 Reduced 28.61%
673,145 $22 Million
Q4 2019

Feb 11, 2020

SELL
$32.92 - $37.36 $52 Million - $59 Million
-1,579,218 Reduced 62.62%
942,884 $36.9 Million
Q3 2019

Nov 08, 2019

SELL
$32.49 - $42.13 $11.8 Million - $15.3 Million
-362,198 Reduced 12.56%
2,522,102 $90.6 Million
Q2 2019

Aug 12, 2019

BUY
$36.98 - $41.52 $63.6 Million - $71.4 Million
1,720,600 Added 147.86%
2,884,300 $126 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $74 Million - $81.3 Million
-1,974,412 Reduced 62.92%
1,163,700 $49.4 Million
Q4 2018

Feb 15, 2019

SELL
$38.47 - $43.86 $32.2 Million - $36.7 Million
-837,026 Reduced 21.06%
3,138,112 $130 Million
Q3 2018

Nov 09, 2018

SELL
$34.47 - $41.81 $53.3 Million - $64.6 Million
-1,546,146 Reduced 28.0%
3,975,138 $175 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $50.1 Million - $53.5 Million
1,520,289 Added 38.0%
5,521,284 $200 Million
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $49 Million - $56.8 Million
-1,534,958 Reduced 27.73%
4,000,995 $142 Million
Q4 2017

Feb 02, 2018

BUY
$33.26 - $35.29 $52.3 Million - $55.5 Million
1,572,406 Added 39.67%
5,535,953 $201 Million
Q3 2017

Nov 06, 2017

BUY
$31.0 - $34.15 $123 Million - $135 Million
3,963,547
3,963,547 $141 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ci Investments Inc. Portfolio

Follow Ci Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.